Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; 21 of the 34 sources its claims cite were checked for support.

Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis

Open access

Abstract

Abstract Introduction Aortic valve stenosis (AS) is a progressive disease characterized by the calcification and narrowing of the aortic valve, leading to significant morbidity and mortality. Early detection and risk stratification remain a major clinical challenge. Identifying specific biomarkers could significantly improve risk prediction and disease management. Objective This study aims to (1) identify novel plasma protein biomarkers for incident AS, (2) establish causal relationships using genetic approaches, and (3) prioritize biomarkers specific to the aortic valve tissue. Methods We assessed the association between 2,923 unique plasma proteins measured using the Olink Explore assay and AS incidence in 52,632 UK Biobank participants with 487 incident AS cases over a median follow-up of 13 years. Multivariable Cox proportional hazards models were used to evaluate associations adjusted for cardiovascular risk factors. A stratified analysis was performed to investigate the association in men and women separately. For causal inference, we used protein quantitative trait loci (pQTL) Mendelian Randomization (MR). We then verified the aortic valve specificity of the proteins using our transcriptomic dataset of 500 human aortic valves. Using expression QTL (eQTL)-based MR, we evaluated the causal role of gene expression in AS and performed colocalization analyses. Results Our fully adjusted model identified 55 proteins significantly associated with AS incidence, with GDF15 showing the strongest association (HR=1.93 per SD, 95% CI: 1.67–2.23, P value = 3.3E-19). In sex-stratified analyses, 10 proteins showed a significant association with AS incidence in women, including 5 more strongly associated in women (CD38, CD80, IGFBPL1, NFASC, SERPINA9, P interaction <0.05), whereas 16 proteins were identified in men including 1 protein (REG1A) with a significantly stronger association in men. pQTL-MR suggested a potential causal role for 4 proteins (PCSK9, CHI3L1, NFASC, PRSS8). Transcriptomic integration confirmed high aortic valve expression for 11 candidates, with three genes demonstrating significant associations in aortic valve eQTL MR analyses, including LTBP2, for which the pQTL and eQTL colocalized. Conclusion The integration of proteomics and genomics allowed the identification of potential biomarkers and drug targets for AS, showing evidence of causality and tissue-specific expression.

Overview

CoChat Summary

TL;DR

In 52,632 UK Biobank participants with 487 incident aortic valve stenosis (AS) cases, 55 plasma proteins were associated with AS after full adjustment, and integration with pQTL/eQTL Mendelian randomization and aortic valve transcriptomics prioritized potentially causal, valve-specific candidates including PCSK9, LTBP2, COL4A1, and B2M.

Key findings

  • In the fully adjusted Cox model (age, sex, BMI, smoking, eGFR, ancestry, SBP, LDL-C), 55 of 2,923 Olink proteins were significantly associated with incident AS; GDF15 was strongest (HR = 1.93 per SD, 95% CI 1.67–2.23, P = 3.26E-19). The base model (age, sex) identified 424 proteins (406 positive, 18 negative), with GDF15 at HR = 2.25 per SD (95% CI 2.02–2.52, P = 3.79E-46).
  • Sex-stratified analyses found 10 significant proteins in women (n = 28,451; strongest IGFBP7, HR = 2.25 per SD, 95% CI 1.70–2.98, P = 1.49E-08) and 16 in men (n = 24,181; strongest GDF15, HR = 2.06 per SD, 95% CI 1.73–2.45, P = 8.09E-16). Six proteins met both sex-stratified significance and interaction criteria: 5 female-predominant (CD38, CD80, IGFBPL1, NFASC, SERPINA9) and 1 male-specific (REG1A).
  • pQTL-MR among the 55 fully adjusted proteins identified 4 with robust causal evidence: PCSK9 (OR = 1.18 per SD, 95% CI 1.12–1.24, P = 2.66E-10), CHI3L1 (OR = 1.03, 95% CI 1.02–1.05, P = 6.42E-5), NFASC (OR = 1.06, 95% CI 1.02–1.10, P = 0.005), and PRSS8 (OR = 1.32, 95% CI 1.07–1.64, P = 0.01).
  • Eleven genes showed high aortic valve expression (>78 TPM); eQTL-MR was significant for COL4A1 (OR = 1.32 per SD, 95% CI 1.10–1.59, P = 0.003), LTBP2 (OR = 1.21, 95% CI 1.05–1.40, P = 0.01), and B2M (OR = 1.21, 95% CI 1.07–1.36, P = 0.02). Only LTBP2 colocalized between aortic valve eQTLs and plasma pQTLs (PP.H4 = 0.93), and between valve and aorta eQTLs (PP.H4 = 0.88); COL4A1 and B2M showed PP.H4 < 0.5. Six of ten prioritized genes had DGIdb interaction scores >0.1, with approved agents targeting B2M, COL4A1, PCSK9, REG1A, and REN.

Methods

  • Prospective cohort study in UK Biobank Pharma Proteomics Project participants (n = 52,632; 54.1% female), with 2,923 unique plasma proteins measured by Olink Explore and incident AS defined by ICD codes I35.0/I35.2 over a median 13-year follow-up (487 cases). Multivariable Cox proportional hazards models (base and fully adjusted) with Bonferroni threshold P < 1.7E-5, plus sex-stratified and sex-interaction analyses; pathway enrichment via Metascape.
  • Two-sample MR using deCODE pQTLs (SomaScan, 35,559 Icelanders) as exposure and an AS GWAS meta-analysis (14,819 cases, 927,044 controls) as outcome; cis-variants within 500 kb, LD clumping r² < 0.1, minimum 3 instruments, IVW primary with weighted median and MR-Egger sensitivity analyses.
  • Aortic valve specificity assessed by bulk RNA-seq of 500 human aortic valves (60 healthy from transplant recipients, 440 diseased from AVR patients); cis-eQTL MR (±500 kb, FDR < 5%) for highly expressed genes, Bayesian colocalization (COLOC v3.2.1, PP.H4 > 0.75 threshold) with UKB-PPP pQTLs and GTEx aorta eQTLs, and druggability via DGIdb v5.0.

Limitations

  • Stated: analysis focused mainly on European ancestry (93.2%), limiting generalizability; sex-stratified GWAS summary statistics were unavailable, so MR was performed in a combined sample and may obscure sex-specific genetic effects; functional validation and mechanistic in vitro/in vivo studies are required to confirm findings.
  • Evident from the text: the observational cohort had only 487 incident AS cases, and the MR instrument set was reduced (325 of 424 base-model proteins available in deCODE; 180 retained after requiring ≥3 variants), which limits power; the pQTL and eQTL analyses used different cohorts and platforms (deCODE SomaScan vs UKB-PPP Olink), and X/Y chromosome proteins were excluded.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1101/2025.11.27.25339923

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

19 Valid · 1 Not valid · 7 Not checked · 66 Own results and interpretations

37 more claims · 1 with their cited sources checked

Create a free account to see all 93 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 29
  • It may state two separate claims as one. 32
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 49 references

Metadata

Authors
Zamani, P., Houessou, U., Manikpurage, H. D., Dahmene, M., Li, Z., Gaudreault, N., Clavel, M.-A., Pibarot, P., Mathieu, P., Arsenault, B. J., Eslami, A., Bossé, Y., & Thériault, S.
Affiliations
Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Corresponding author
Thériault, Sébastien
Venue
medRxiv
Publisher
openRxiv
Published
2025-11-30
OpenAlex
W4416830976
Cited by
0
References
49
Type
posted content
Language
en
Open access
Locations
medRxiv (acceptedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
Keywords
aortic stenosis, plasma protein biomarkers, GDF15, PCSK9, YKL-40, LTBP2, sex differences, protein quantitative trait loci, expression quantitative trait loci, causal inference, disease incidence, risk prediction, therapeutic target, aortic valve calcification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis. https://app.cochat.ai/papers/10.1101/2025.11.27.25339923
The paper
Zamani, P., Houessou, U., Manikpurage, H. D., Dahmene, M., Li, Z., Gaudreault, N., Clavel, M.-A., Pibarot, P., Mathieu, P., Arsenault, B. J., Eslami, A., Bossé, Y., & Thériault, S. (2025). Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis. medRxiv. https://doi.org/10.1101/2025.11.27.25339923

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.